Back

CDKN1A (p21Cip/Waf1) stabilizes Cyclin D3 by inhibiting its phosphorylation-dependent nuclear export following butyrate treatment

Ghrib, M. A.; Dayhoff, G. W.; Chahtour, C.; Rodrigues-Machado, C.; Youssef, A.; Schillaci, G.; Gautreau, G.; Henry, C.; Uversky, V. N.; Rigolet, P.; Blottiere, H. M.; Lelievre, J.-M.

2025-06-20 cell biology
10.1101/2025.06.19.660543 bioRxiv
Show abstract

Butyrate-mediated inhibition of cell proliferation is part of the preventive role of dietary fiber against colorectal cancer (CRC). This effect notably involves the cyclin-dependent kinase inhibitor CDKN1A (p21Cip/Waf1) in human intestinal cells, yet the underlying molecular mechanisms remain incompletely understood. Previously, we observed a paradoxical increase in cyclin D3 (CCND3)--but not cyclin D1--levels upon butyrate exposure. Here, we demonstrate that the butyrate-induced accumulation of CCND3 protein results both from mRNA increase and a CDKN1A-dependent protein stabilization, specifically extending its nuclear half-life. Proteomic analyses of CCND3 co-immunoprecipitates identified complexes involving CDKN1A, CDK4, CDK6, and the CRC-associated kinase CDK5, particularly enriched in butyrate-treated cells. Phosphorylation at a conserved Thr residue, crucial for CCND nuclear export and subsequent proteasomal degradation, was notably reduced following butyrate treatment and inversely correlated with CDKN1A expression levels. Structural modeling based on AlphaFold2, complemented by molecular dynamics simulations, revealed possible differential interactions between CDKN1A and cyclins D1 and D3, predicting that CCND3-Thr283 becomes structurally buried upon CDKN1A binding, limiting its phosphorylation. Our findings provide novel mechanistic insights into how CDKN1A might regulate CCND3 stability, highlighting previously unexplored roles of cyclin D3-containing complexes in cell cycle arrest induced by butyrate.

Matching journals

The top 12 journals account for 50% of the predicted probability mass.

1
Cellular and Molecular Life Sciences
84 papers in training set
Top 0.1%
6.4%
2
Nature Communications
4913 papers in training set
Top 28%
6.4%
3
Scientific Reports
3102 papers in training set
Top 23%
4.9%
4
Frontiers in Molecular Biosciences
100 papers in training set
Top 0.1%
4.9%
5
eLife
5422 papers in training set
Top 19%
4.4%
6
International Journal of Molecular Sciences
453 papers in training set
Top 2%
4.4%
7
Frontiers in Cell and Developmental Biology
218 papers in training set
Top 1%
4.4%
8
Cell Reports
1338 papers in training set
Top 13%
4.0%
9
EMBO reports
136 papers in training set
Top 0.8%
3.6%
10
Redox Biology
64 papers in training set
Top 0.2%
3.1%
11
Molecular Metabolism
105 papers in training set
Top 0.7%
2.6%
12
Gut Microbes
70 papers in training set
Top 0.4%
2.4%
50% of probability mass above
13
iScience
1063 papers in training set
Top 9%
2.1%
14
Communications Biology
886 papers in training set
Top 5%
2.1%
15
Advanced Science
249 papers in training set
Top 9%
1.9%
16
Gastroenterology
40 papers in training set
Top 1.0%
1.7%
17
Cells
232 papers in training set
Top 2%
1.7%
18
The FASEB Journal
175 papers in training set
Top 1%
1.7%
19
The FEBS Journal
78 papers in training set
Top 0.2%
1.7%
20
Biochimica et Biophysica Acta (BBA) - Molecular Cell Research
28 papers in training set
Top 0.2%
1.5%
21
Structure
175 papers in training set
Top 2%
1.3%
22
Neoplasia
22 papers in training set
Top 0.3%
1.3%
23
PLOS ONE
4510 papers in training set
Top 60%
1.2%
24
Cell Communication and Signaling
35 papers in training set
Top 0.6%
1.2%
25
Molecular & Cellular Proteomics
158 papers in training set
Top 1%
1.2%
26
Science Advances
1098 papers in training set
Top 23%
1.2%
27
Cancers
200 papers in training set
Top 4%
0.9%
28
PLOS Computational Biology
1633 papers in training set
Top 24%
0.8%
29
Journal of Experimental & Clinical Cancer Research
25 papers in training set
Top 0.3%
0.8%
30
Developmental Cell
168 papers in training set
Top 11%
0.8%